Caitlin Raymond: When Technology Meets Physiology in Neonatal Patients
Caitlin Raymond, a board-certified Clinical Pathologist and current Transfusion Medicine Fellow at the National Institutes of Health, shared on LinkedIn:
”When innovation meets its limits — and why that matters for the smallest patients.
I was recently consulted on a premature infant, six weeks old and just 2.5 kg, already on ECMO and now facing sepsis.
The ICU team requested plasmapheresis for a presumed cytokine storm — a reasonable thought under the ASFA guidelines.
But when I calculated the baby’s total blood volume — only 250 mL — it became clear the procedure simply wasn’t possible.
Even with the best intentions and sound rationale, the machine itself had limits: the Terumo system requires a minimum 300 mL TBV, 10 % Hct, and 0.5 L plasma volume.
We ultimately recommended a whole blood exchange, the only feasible path forward for cytokine and toxin removal.
This case was a humbling reminder that in transfusion medicine, the boundaries of care aren’t always physiologic — sometimes they’re mechanical.
As technology evolves, we must continue to advocate for innovation that reaches every patient, not just the ones who fit within device specifications.
Read the full reflection here.”
Stay updated with Hemostasis Today.
-
Apr 23, 2026, 18:19Chokri Ben Lamine: Choosing the Right LMWH in Cancer Patients
-
Apr 23, 2026, 17:57Shalini R: Not All Blood Thinners Are the Same
-
Apr 23, 2026, 17:33Abdulaziz (Omar) Badran: Navigating the Clinical Complexity of Combined Red Cell Disorders
-
Apr 23, 2026, 17:19Kate Thomas: One Hour, One Donation, One Life Saved
-
Apr 23, 2026, 17:19Ameneh Eshghinejad: The First 72 Hours After SAH Are Critical for Balancing the Risks of Rebleeding and Thromboembolism
-
Apr 23, 2026, 17:18Katarina Ziakova: The WFH Shared Decision – Making Tool Is Driving Critical Conversations in Haemophilia Care
-
Apr 23, 2026, 17:14Paulus Kirchhof: Can We Improve Prevention of Cardiovascular Diseases?
-
Apr 23, 2026, 17:08Wolfgang Miesbach: 5‑Year Gene Therapy Data from WFH Congress 2026
-
Apr 23, 2026, 17:05Veronica Sanchez: The 2026 Guideline on the Management of Dyslipidemia